Mode
Home
Conditions Medications Drug Pipeline Weekly Digests
Text Size
Log in / Sign up
Home › Medications › ARNI

ARNI

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Registry study links ARNI therapy groups to divergent mortality and hospitalization risks in HFrEF patients.
Cardiology
Registry study links ARNI therapy groups to divergent mortality and hospitalization risks in HFrEF patients. Your Heart's Upper Chamber Holds the Key to Survival
This multicenter registry study analyzed 1,182 patients with HFrEF receiving ARNI-based therapy. The authors observed that Group B faced sig…
Doctors need to look at both the top and bottom of the heart to truly know if a patient is safe.
medRxiv Apr 24, 2026
SGLT2i use linked to lower adherence and QOL in HF patients in cross-sectional MTAC study
Cardiology Cohort
SGLT2i use linked to lower adherence and QOL in HF patients in cross-sectional MTAC study Taking More Heart Pills May Actually Feel Better, Not Worse
A cross-sectional study of 78 heart failure patients in a Malaysian MTAC program found SGLT2i users had significantly lower adherence (p = 0…
Heart failure patients taking more heart medicines reported feeling better, not worse, in a new study from Malaysia.
Frontiers Apr 16, 2026